Costs Dilemmas over Drugs for Cancer

CancerThe National Institute for Health and Clinical Excellence has decided that Avastin is not a cost-effective treatment for advanced bowel cancer, as was reported yesterday, August 24.

It estimates it would cost the NHS about £135m (over $208m) a year to treat 6,500 people at £20,800 ($32,000) per person and the limited extension to life that Avastin provides cannot be justified.

“Never mind,– the government says. – This is why we’re setting up the Cancer Drugs Fund of £50m ($77m) to pay for these expensive treatments. But the money won’t even fund this one treatment for all its potential beneficiaries – never mind the next wonder drug that comes along.”

Leave a comment: